1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe and Middle East & Africa Poultry Vaccines Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe and Middle East & Africa Poultry Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe and Middle East & Africa Poultry Vaccines Market Regional Analysis
6.2 Europe and Middle East & Africa Poultry Vaccines Market Revenue 2019-2028 (US$ Million)
6.3 Europe and Middle East & Africa Poultry Vaccines Market Forecast Analysis
7. Europe and Middle East & Africa Poultry Vaccines Market Analysis – by Dosage
7.1 Duct Vaccines
- 7.1.1 Overview
- 7.1.2 Duct Vaccines: Europe and Middle East & Africa Poultry Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Liquid Vaccines
- 7.2.1 Overview
- 7.2.2 Liquid Vaccines: Europe and Middle East & Africa Poultry Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Freeze-Dried Vaccines
- 7.3.1 Overview
- 7.3.2 Freeze-Dried Vaccines: Europe and Middle East & Africa Poultry Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Europe and Middle East & Africa Poultry Vaccines Market Analysis – by Disease
8.1 Infectious Bronchitis
- 8.1.1 Overview
- 8.1.2 Infectious Bronchitis: Europe and Middle East & Africa Poultry Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Avian Influenza
- 8.2.1 Overview
- 8.2.2 Avian Influenza: Europe and Middle East & Africa Poultry Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Marek's Disease
- 8.3.1 Overview
- 8.3.2 Marek's Disease: Europe and Middle East & Africa Poultry Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.4 Newcastle Disease
- 8.4.1 Overview
- 8.4.2 Newcastle Disease: Europe and Middle East & Africa Poultry Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Europe and Middle East & Africa Poultry Vaccines Market Analysis – by Technology
9.1 Toxoid Vaccines
- 9.1.1 Overview
- 9.1.2 Toxoid Vaccines: Europe and Middle East & Africa Poultry Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Recombinant Vaccines
- 9.2.1 Overview
- 9.2.2 Recombinant Vaccines: Europe and Middle East & Africa Poultry Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Inactivated Vaccines
- 9.3.1 Overview
- 9.3.2 Inactivated Vaccines: Europe and Middle East & Africa Poultry Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.4 Live Attenuated Vaccines
- 9.4.1 Overview
- 9.4.2 Live Attenuated Vaccines: Europe and Middle East & Africa Poultry Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. Europe and Middle East & Africa Poultry Vaccines Market – Middle East and Africa Analysis
10.1 Overview
10.2 Europe
- 10.2.1 Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.2.1.1 Europe and Middle East & Africa Poultry Vaccines Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 UK:
Europe and Middle East & Africa Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 UK: Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Dosage
- 10.2.1.1.2 UK: Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Disease
- 10.2.1.1.3 UK: Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Technology
- 10.2.1.2 Germany:
Europe and Middle East & Africa Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Germany: Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Dosage
- 10.2.1.2.2 Germany: Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Disease
- 10.2.1.2.3 Germany: Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Technology
- 10.2.1.3 France:
Europe and Middle East & Africa Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 France: Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Dosage
- 10.2.1.3.2 France: Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Disease
- 10.2.1.3.3 France: Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Technology
- 10.2.1.4 Russia:
Europe and Middle East & Africa Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.4.1 Russia: Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Dosage
- 10.2.1.4.2 Russia: Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Disease
- 10.2.1.4.3 Russia: Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Technology
- 10.2.1.5 Italy:
Europe and Middle East & Africa Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.5.1 Italy: Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Dosage
- 10.2.1.5.2 Italy: Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Disease
- 10.2.1.5.3 Italy: Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Technology
- 10.2.1.6 Rest of Europe :
Europe and Middle East & Africa Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.6.1 Rest of Europe : Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Dosage
- 10.2.1.6.2 Rest of Europe : Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Disease
- 10.2.1.6.3 Rest of Europe : Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Technology
10.3 Middle East and Africa
- 10.3.1 Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.3.1.1 Europe and Middle East & Africa Poultry Vaccines Market – Revenue and
Forecast Analysis – by Country
- 10.3.1.1 South Africa:
Europe and Middle East & Africa Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 10.3.1.1.1 South Africa: Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Dosage
- 10.3.1.1.2 South Africa: Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Disease
- 10.3.1.1.3 South Africa: Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Technology
- 10.3.1.2 Saudi Arabia:
Europe and Middle East & Africa Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 10.3.1.2.1 Saudi Arabia: Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Dosage
- 10.3.1.2.2 Saudi Arabia: Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Disease
- 10.3.1.2.3 Saudi Arabia: Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Technology
- 10.3.1.3 UAE:
Europe and Middle East & Africa Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 10.3.1.3.1 UAE: Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Dosage
- 10.3.1.3.2 UAE: Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Disease
- 10.3.1.3.3 UAE: Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Technology
- 10.3.1.4 Rest of Middle East and Africa:
Europe and Middle East & Africa Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 10.3.1.4.1 Rest of Middle East and Africa: Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Dosage
- 10.3.1.4.2 Rest of Middle East and Africa: Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Disease
- 10.3.1.4.3 Rest of Middle East and Africa: Europe and Middle East & Africa Poultry Vaccines Market Breakdown, by Technology
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Boehringer Ingelheim International GmbH
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Biovac
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Zoetis, Inc.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 CEVA
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Phibro Animal Health Corporation
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Virbac
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Hester Biosciences Limited
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Merck & Co., Inc.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Venky’s India
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 AniCon GmbH
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Get Free Sample For Europe and Middle East & Africa Poultry Vaccines Market
